Cas:1407516-48-6 2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate manufacturer & supplier

We serve Chemical Name:2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate CAS:1407516-48-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate

Chemical Name:2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate
CAS.NO:1407516-48-6
Synonyms:2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate
Molecular Formula:C14H19BrN4O4
Molecular Weight:387.22900
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:91.49000
Exact Mass:386.05900
LogP:3.33550

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate Use and application,2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate technical grade,usp/ep/jp grade.


Related News: ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. 2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate manufacturer ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. 2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate supplier The first is the API �C which is the central ingredient. 2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate vendor Ultimately there’s likely a broad mix of social, cultural and economic drivers at play, suggested Lona Sandon, program director of the Department of Clinical Nutrition in the School of Health Professions at the UT Southwestern Medical Center in Dallas. She was not part of the research. 2-Methyl-2-propanyl 4-(3-bromo-5-nitro-4-pyridinyl)-1-piperazinec arboxylate factory Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it.